You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for In Re: Zetia (Ezetimibe) Antitrust Litigation (E.D. Va. 2018)

✉ Email this page to a colleague

« Back to Dashboard

In Re: Zetia (Ezetimibe) Antitrust Litigation (E.D. Va. 2018)

Docket	⤷ Sign Up	Date Filed	2018-06-15
Court	District Court, E.D. Virginia	Date Terminated	2023-12-14
Cause	15:1 Antitrust Litigation	Assigned To	Rebecca Beach Smith
Jury Demand	Plaintiff	Referred To	Douglas E. Miller
Patents	7,030,106; 7,612,058; RE37,721; RE42,461
Link to Docket	External link to docket

Small Molecule Drugs cited in In Re: Zetia (Ezetimibe) Antitrust Litigation

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for In Re: Zetia (Ezetimibe) Antitrust Litigation (E.D. Va. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2020-09-11	1113		claimed three patents associated with Zetia, Patent Nos. 5,846,966, RE7721 and 7,030,106, and Glenmark… for all three patents.17 Merck sued Glenmark for infringement of the RE7721 patent on March 23, 2007.18…has received final approval from the FDA.9 Patents and several types of exclusivities may prevent …prevent final approval of an ANDA.10 Where patents or other exclusivity barriers are in place, but the FDA…final approval will not be granted until the patent or exclusivity issues have been resolved.12 One	External link to document
2018-09-05	128	Amended Complaint	as U.S. Patent No. 7,030,106. The ’106 patent was Merck’s first sterol non-absorption patent. It has…azetidinone patents include the ’365 patent, the ’115 patent, the ’966 patent, the RE’721 patent, and the…three patents for these discoveries (one reissued as U.S. Patent No. RE37,721 (the “RE’721 patent”)).… 5. Patents are not bulletproof. 43. Patents are not bulletproof. Patents are routinely… A patent is also invalid or unenforceable when a later acquired patent is not patentably distinct	External link to document
2018-09-13	130	Amended Complaint	as U.S. Patent No. 7,030,106. The ’106 patent was Merck’s first sterol non-absorption patent. It has…azetidinone patents include the ’365 patent, the ’115 patent, the ’966 patent, the RE’721 patent, and the… Patents are not bulletproof. 48. Patents are not bulletproof. Patents are routinely… A patent is also invalid or unenforceable when a later acquired patent is not patentably distinct…azetidinone patent application – issued as U.S. Patent No. 5,631,365. The ’365 patent was the first-issued	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.